Latest James L. Gulley Stories
Cancer Immunotherapy Month Focuses on Raising Awareness for the Most Promising Form of Cancer Treatment Today New York (PRWEB) May 20, 2015 Cancer immunotherapy,
Data from KEYNOTE-006 Study Presented at AACR Annual Meeting and Published in the New England Journal of Medicine KIRKLAND, QC, April 19, 2015 /CNW Telbec/ - Merck (NYSE: MRK),
Researchers at Roswell Park Cancer Institute have begun a phase I clinical research study to assess the safety and efficacy of a novel immunotherapy vaccine as treatment for melanoma.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).